How useful is epsilon-aminocaproic acid for the treatment of hyperfibrinolysis in patients with cirrhosis?
Nat Clin Pract Gastroenterol Hepatol
.
2006 Jul;3(7):370-1.
doi: 10.1038/ncpgasthep0526.
Authors
Patrick G Northup
1
,
Stephen H Caldwell
Affiliation
1
Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, VA 22908-0708, USA. pgn5qs@virginia.edu
PMID:
16819496
DOI:
10.1038/ncpgasthep0526
No abstract available